11/18
04:04 pm
zntl
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval [Seeking Alpha]
Low
Report
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval [Seeking Alpha]
11/16
01:10 am
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was upgraded by analysts at
Wall
Low
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was upgraded by analysts at
Wall
11/12
12:34 pm
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its price target lowered by analysts at Morgan Stanley from $8.00 to $4.00. They now have an "equal weight" rating on the stock.
Low
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its price target lowered by analysts at Morgan Stanley from $8.00 to $4.00. They now have an "equal weight" rating on the stock.
11/11
10:08 am
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Medium
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
11/11
07:03 am
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "market perform" rating reaffirmed by analysts at Leerink Partners.
Medium
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "market perform" rating reaffirmed by analysts at Leerink Partners.
11/10
04:05 pm
zntl
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
Medium
Report
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
11/3
05:25 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/3
08:15 am
zntl
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Medium
Report
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
10/24
12:27 pm
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/13
04:20 pm
zntl
Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
10/13
04:05 pm
zntl
Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Medium
Report
Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/8
12:39 pm
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/6
12:00 pm
zntl
Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock [Yahoo! Finance]
Low
Report
Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock [Yahoo! Finance]
10/3
03:48 pm
zntl
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
06:14 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
10/1
05:20 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)